Ticker > Company >

Accent Microcell share price

Accent Microcell Ltd.

NSE: ACCENTMIC SECTOR: Pharmaceuticals & Drugs  7947   24   0

294.75
+49.00 (19.94%)
NSE: 23 Dec 03:56 PM

Price Summary

Today's High

₹ 294.9

Today's Low

₹ 250

52 Week High

₹ 364

52 Week Low

₹ 224

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

620.24 Cr.

Enterprise Value

560.54 Cr.

No. of Shares

2.1 Cr.

P/E

20.56

P/B

3.79

Face Value

₹ 10

Div. Yield

0.41 %

Book Value (TTM)

₹  77.86

CASH

72.49 Cr.

DEBT

12.79 Cr.

Promoter Holding

55.09 %

EPS (TTM)

₹  14.34

Sales Growth

24.45%

ROE

28.17 %

ROCE

30.16%

Profit Growth

146.63 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year24.45%
3 Year22.8%
5 YearNA

Profit Growth

1 Year146.63%
3 Year84.51%
5 YearNA

ROE%

1 Year28.17%
3 Year25.97%

ROCE %

1 Year30.16%
3 Year25.25%

Debt/Equity

0.0781

Price to Cash Flow

54.75

Interest Cover Ratio

32.8763

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 55.09 0.00
Mar 2024 55.09 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 22.8010484490161% for the Past 3 years.
  • The company has significantly decreased its debt by 10.0205 Cr.
  • Company has been maintaining healthy ROE of 25.9680347843165% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.24582689999% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 32.8763.
  • Company’s PEG ratio is 0.397695688504772.
  • The company has an efficient Cash Conversion Cycle of 50.9664 days.
  • Company has a healthy liquidity position with current ratio of 3.7023.
  • The company has a high promoter holding of 55.09%.
  • Promoter stake has increased from 0% to 55.09% in the last 1 quarter.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 132.57 165.71 197.27 245.5
Total Expenditure 121.88 152.74 178.32 206.03
Operating Profit 10.69 12.97 18.95 39.47
Other Income 2.25 1.83 2.49 3.63
Interest 3.38 3.07 2.53 1.15
Depreciation 3.55 4.15 4.11 4.43
Exceptional Items 0 0 0 -1
Profit Before Tax 6 7.59 14.8 36.53
Tax 1.2 1.7 2.57 6.36
Net Profit 4.8 5.89 12.23 30.17
Adjusted EPS (Rs.) 3.72 1.52 9.45 14.34

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.3 12.9 12.94 21.04
Total Reserves 22.33 19.19 37.48 142.79
Borrowings 17.84 6.93 5.47 1.5
Other N/C liabilities 1.46 1.66 1.12 1.65
Current liabilities 34.78 53.92 56.2 46.47
Total Liabilities 80.7 94.61 113.23 213.46
Assets
Net Block 30.4 30.12 31.31 29.04
Capital WIP 0 0 0 1.86
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0.56 0.57 1.71 10.5
Other N/C Assets 0 0 0.06 0
Current Assets 49.75 63.92 80.15 172.06
Total Assets 80.7 94.61 113.23 213.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 6 7.59 14.8 36.53
Adjustment 3.17 6.75 6.27 5.97
Changes in Assets & Liabilities -2.94 2.19 -10.8 -24.87
Tax Paid -1.19 -1.66 -2.54 -6.08
Operating Cash Flow 5.04 14.87 7.57 11.33
Investing Cash Flow -6.27 -4.3 -4.04 -82.34
Financing Cash Flow -2.19 -9.67 -4.32 72.27
Net Cash Flow -3.42 0.9 -0.79 1.26

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Sep 2024%
promoters 55.09 55.09
arvindbhai manibhai patel... - 0.64
chetanaben jitendrakumar ... 0.06 0.06
ghanshyam arjanbhai patel... 12.50 12.50
het ghanshyambhai patel 0.15 0.15
jahanvi ghanshyambhai pat... 0.10 0.10
jitendra vadilal patel 0.38 0.38
jyotiben ghanshyambhai pa... 0.10 0.10
kanchanben shaileshbhai p... 0.10 0.10
nitin jasvantbhai patel 15.59 15.59
princy shaileshbhai patel... 0.10 0.10
rajan arvindbhai chhabhai... 0.02 0.02
samip vasantbhai patel 0.06 0.06
shaileshbhai arjanbhai pa... 0.75 0.75
shrey vinodkumar chhabhai... 0.02 0.02
vasant vadilal patel 9.19 9.19
vinodbhai manibhai patel 15.34 15.34
arvindkumar manibhai pate... 0.64 -
PARTICULARS Mar 2024% Sep 2024%
investors 44.91 44.91
kantilal pachan vadia 9.19 9.19
manoj agarwal 1.37 1.25
negen undiscovered value ... 1.56 1.56

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Accent Microcell Stock Price Analysis and Quick Research Report. Is Accent Microcell an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Accent Microcell and its performance over the period of time. Accent Microcell stock price today is Rs 294.75.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Accent Microcell cash from the operating activity was Rs 11.3295 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Accent Microcell has a Debt to Equity ratio of 0.0781 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Accent Microcell , the EPS growth was 51.6967 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Accent Microcell has OPM of 16.0783518222974 % which is a good sign for profitability.
     
  • ROE: Accent Microcell have a healthy ROE of 28.1673 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Accent Microcell is Rs 294.75. One can use valuation calculators of ticker to know if Accent Microcell share price is undervalued or overvalued.
Last Updated on:
Brief about Accent Microcell
X